移植诊断公司CareDx（股票代码：CDNA）周三盘后股价大跌6.10%，主要原因是该公司公布的季度业绩未能达到分析师预期。
根据CareDx发布的财报显示，截至6月30日的季度调整后每股收益为0.10美元，低于分析师平均预期的0.12美元。公司营收同比下降6.1%至8668万美元，同样低于分析师预期的9062万美元。此外，CareDx当季净亏损857万美元，每股报告亏损0.16美元。
这份疲软的财报直接影响了投资者信心。值得注意的是，CareDx股价在过去三个月中已下跌了34.2%，今年迄今为止累计跌幅达40.0%。尽管如此，分析师对该公司的平均评级仍维持在"买入"，12个月目标价中位数为26.00美元，较最新收盘价有约50.6%的上涨空间。这表明尽管短期业绩不佳，但市场对CareDx的长期前景仍保持乐观态度。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.